Primary Record
1134156-31-2
- In stock
- 9,746 g
- Purity
- 99.7 %
- CAS
- 1134156-31-2
Compound Identifiers & Properties
- CAS
- 1134156-31-2
- PubChem CID
- 25195348
- SMILES
- C1=CC(=CC=C1COC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C4=NC=NC(=C4N=C3NCC5=CC(=C(C=C5)Cl)Cl)N)O)O)C#N
- Canonical SMILES
- N#Cc1ccc(COC[C@H]2O[C@@H](n3c(NCc4ccc(Cl)c(Cl)c4)nc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1
Names & Synonyms
- 1134156-31-2
- VER-155008
- VER 155008
- VER155008
- C25H23Cl2N7O4
- 4io8
- RefChem:933968
- 5'-O-[(4-Cyanophenyl)methyl]-8-[[(3,4-dichlorophenyl)methyl]amino]-adenosine
- D0H0AU
- MFCD18086892
- MLS006010638
- CHEMBL470334
- orb1300147
- adenosine-derived inhibitor, 12
- SCHEMBL16046542
- SCHEMBL29349766
- SCHEMBL30132826
- BDBM32378
- CHEBI:95010
- CTK8B9488
- DTXSID00649014
- ZXGGCBQORXDVTE-UMCMBGNQSA-N
- GLXC-04392
- BCP11966
- EX-A2275
- 2290AA
- ANW-62597
- s7751
- ZINC43208321
- AKOS016003983
- Hsp 70 inhibitor (cancer), Vernalis
- CCG-270034
- CS-3823
- QC-9937
- VER155008?
- NCGC00263143-02
- NCGC00263143-04
- AC-33008
- AS-73530
- BC600787
- CID:25195348
- DA-68559
- FD144776
- HY-10941
- SMR004701641
- adenosine-derived inhibitor (Grp78), 13
- SID:347912321
- TC-151342
- VER-155008;VER155008
- A4387
- ST24044025
- J3.255.233A
- A13351
- F12804
- Adenosine, 5'-O-[(4-cyanophenyl)methyl]-8-[[(3,4-dichlorophenyl)methyl]amino]-
- VER-155008, >=98% (HPLC)
- A848921
- C550733
- 5'-O-[(4-Cyanophenyl)methyl]-8-[[(3,4-dichlorophenyl)-methyl]amino]-adenosine
- Heat shock protein 70 inhibitor (cancer), Vernalis
- 8-(3,4-Dichlorobenzyl)amino-5-O-(4-cyano-benzyl)adenosine
- BRD-K32330832-001-01-0
- Q27166771
- 4-((((2R,3S,4R,5R)-5-(6-Amino-8-((3,4-dichlorobenzyl)amino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)methyl)benzonitrile
- 8-(3,4-Dichlorobenzyl)amino-5'-O-(4-cyanobenzyl)adenosine
- B1370-272446
- 4-({[(2R,3S,4R,5R)-5-(6-amino-8-{[(3,4-dichlorophenyl)methyl]amino}-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)benzonitrile
- 4-[[(2R,3S,4R,5R)-5-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxymethyl]benzonitrile
- 5'-O-(4-cyanobenzyl)-8-[(3,4-dichlorobenzyl)amino]adenosine
- 8-(3,4-Dichlorobenzyl)amino-5'-O-(4-cyano-benzyl)adenosine
- 8-[(3,4-Dichlorobenzyl)amino]-5 -O-(4-cyanobenzyl)adenosine
- 4-((((2R,3S,4R,5R)-5-(6-amino-8-(3,4-dichlorobenzylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)methyl)benzonitrile
- 4-[[(2r,3s,4r,5r)-5-[6-Amino-8-[(3,4-Dichlorophenyl)methylamino]purin-9-Yl]-3,4-Dihydroxy-Oxolan-2-Yl]methoxymethyl]benzonitrile
- 5 -O-(4-Cyanophenyl)methyl-8-[(3,4-dichlorophenyl)methyl]aminoadenosine
- 5'-O-[(4-Cyanophenyl)methyl]-8-[[(3,4-dichlorophenyl)methyl]amino]-Adenosine;
- 5'-O-[(4-Cyanophenyl)methyl]-8-{[(3,4-dichlorophenyl)methyl]amino}adenosine
- 5?-O-[(4-Cyanophenyl)methyl]-8-[[(3,4-dichlorophenyl)methyl]amino]-adenosine
- 3FD
- 4-({[(2R,3S,4R,5R)-5-(6-AMINO-8-{[(3,4-DICHLOROPHENYL)METHYL]AMINO}PURIN-9-YL)-3,4-DIHYDROXYOXOLAN-2-YL]METHOXY}METHYL)BENZONITRILE
- 4-[[(2R,3S,4R,5R)-5-[6-amino-8-[(3,4-dichlorophenyl)methylamino]-9-purinyl]-3,4-dihydroxy-2-oxolanyl]methoxymethyl]benzonitrile
- 4-[[(2R,3S,4R,5R)-5-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxymethyl]benzonitrile
- C07